Inflammasomes in cancer: a double-edged sword

Abstract

Chronic inflammatory responses have long been observed to be associated with various types of cancer and play decisive roles at different stages of cancer development. Inflammasomes, which are potent inducers of interleukin (IL)-1β and IL-18 during inflammation, are large protein complexes typically consisting of a Nod-like receptor (NLR), the adapter protein ASC, and Caspase-1. During malignant transformation or cancer therapy, the inflammasomes are postulated to become activated in response to danger signals arising from the tumors or from therapy-induced damage to the tumor or healthy tissue. The activation of inflammasomes plays diverse and sometimes contrasting roles in cancer promotion and therapy depending on the specific context. Here we summarize the role of different inflammasome complexes in cancer progression and therapy. Inflammasome components and pathways may provide novel targets to treat certain types of cancer; however, using such agents should be cautiously evaluated due to the complex roles that inflammasomes and pro-inflammatory cytokines play in immunity.

Cited by papers we hold 11

• The role of pyroptosis and its crosstalk with immune therapy in breast cancer · 2022
  Not checked
• A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer · 2021
  No notice
• Inflammasomes as therapeutic targets in human diseases · 2021
  No notice
• Pyroptosis: mechanisms and diseases · 2021
  No notice
• Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment · 2021
  No notice
• NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis · 2019
  No notice
• The role of pyroptosis in cancer: pro-cancer or pro-“host”? · 2019
  No notice
• Pharmacological Inhibitors of the NLRP3 Inflammasome · 2019
  No notice
• Role of the NLRP3 inflammasome in cancer · 2018
  No notice
• Obesity-associated NLRC4 inflammasome activation drives breast cancer progression · 2016
  No notice
• Unique Loss of the PYHIN Gene Family in Bats Amongst Mammals: Implications for Inflammasome Sensing · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.